| 发明名称 | Method for assessing the efficacy of a TR1 cell therapy in a subject | ||
| 摘要 | A method for assessing whether a patient subjected to an antigen-specific Tr1 cell therapy is responding to the treatment, includes: determining in vitro the antigen-specific proliferation of T cells contained in a cell sample from the patient; and comparing the antigen-specific proliferation to a standard reference, thereby determining whether the patient is responding or not to the treatment. | ||
| 申请公布号 | US8815534(B2) | 申请公布日期 | 2014.08.26 |
| 申请号 | US201113878089 | 申请日期 | 2011.10.07 |
| 申请人 | TxCell | 发明人 | Foussat Arnaud;Quatannens Brigitte |
| 分类号 | C12Q1/02;C12N5/00;C12N5/071 | 主分类号 | C12Q1/02 |
| 代理机构 | Young & Thompson | 代理人 | Young & Thompson |
| 主权项 | 1. A method for assessing whether a human patient subjected to an antigen-specific Tr1 cell therapy is responding to the treatment, said method comprising: determining in vitro the antigen-specific proliferation of T cells contained in a cell sample from said patient, comparing said antigen-specific proliferation to a standard reference, thereby determining whether the patient is responding or not responding to the treatment. | ||
| 地址 | Valbonne FR | ||